Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Eloxx Pharmaceuticals Inc. (ELOX)

  • Technical Exchange News
  • Oct. 14, 2023, 05:10 UTC
  • 20
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Curis Inc (CRIS)

  • Technical Exchange News
  • Oct. 14, 2023, 05:10 UTC
  • 20
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Bellerophon Therapeutics Inc. (BLPH)

  • Technical Exchange News
  • Oct. 14, 2023, 05:09 UTC
  • 20
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Neoleukin Therapeutics Inc (NLTX)

  • Technical Exchange News
  • Oct. 10, 2023, 05:14 UTC
  • 21
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 1468
  • 1469
  • 1470

Search

News categories

  • Technical Exchange News(14694)
  • Event(6229)
  • SEC News(393629)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(239586)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin